retatrutide peptide drops Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide Weight Loss | GLP-1,

The main confirmed actions were documented as: stimulating insulin secretion (incretin effect), inhibiting glucagon secretion, inhibiting gastrointestinal motility and secretion (enterogastrone / ileal brake mechanism), and regulating appetite and food intake

This article is based on a recent episode of the You, Diet Sucks podcast called The Science of Semaglutides, Fitness, and Weight Stigma. In the episode, we explore the history of GLP-1 medications, the rise of Ozempic in the fitness world, and what it really means for athletes trying to navigate weight stigma and performance

Do you expect the trend to continue and market access to ease more

As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with

Other FDA approved medications use different mechanisms

Arab thinks increased access could not only address short-term weight loss, but also long-term adjacent medical issues like hypertension that also increase healthcare costs